PTPN7 and melanoma: Uptaken miR-592 inhibits the expression of its target gene protein tyrosine phosphatase non-receptor type 7 (PTPN7), leading to the activation of the MAPK/ERK signaling pathway and, ultimately, to the promotion of melanoma cell metastatic ability [325].